Answers are grounded in this paper and cite their sources.
A human intravenous immunoglobulin preparation containing neutralizing antibodies to respiratory syncytial virus (RSV) was utilized for intratracheal and topical treatment of laboratory-induced RSV infections in owl monkeys (Aotus trivirgatus). Topically administered antibodies induced significant reductions in RSV shedding in the lower respiratory tract.
No takes yet. Share an insight, caveat, or question.
Hemming et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: